Q1 2023 Non-GAAP Operating Income

Consolidated Balance Sheet $ billions Cash and Cash Equivalents AR Trade Pre-paid Expenses and Other Current Assets Inventory Fixed Assets Intangible Assets Goodwill Other Long Term Assets Total Assets AP Trade SR&A AP Other Mar 31, 2023 Dec 31, 2022 Diff 2.1 2.8 (0.7) 3.4 3.7 (0.3) 1.8 1.7 0.1 4.1 3.8 0.3 5.8 5.7 0.0 6.0 6.3 (0.3) 17.8 17.6 0.2 2.4 2.3 0.1 43.5 44.0 (0.5) 2.4 1.9 0.5 3.3 3.8 (0.4) 3.7 3.7 (0.0) Total Debt (ST+LT) 20.7 21.2 (0.5) Other Long Term liabilities 4.8 4.7 0.0 Minority 0.8 0.8 (0.0) Teva Shareholders' Equity 7.9 7.9 (0.0) Total Liabilities & Equity 43.5 44.0 (0.5) | 40 | teva

View entire presentation